3 July 2008
HEALTHY GROWTH IN A COMPETITIVE MARKET FOR COPAPHARM EUROPE
Copapharm Europe SCRL has produced another set of healthy trading figures from the 2007 financial year.
Achieving solid 10% growth on the previous year, both organically and through shareholder expansion, the pharmaceutical packaging and labelling alliance posted a total turnover in 2007 of 294.3 million euros over 264.8 million euros in 2006. Of this turnover, 85% was in pharmaceutical and health care packaging and labelling, with the remaining 15% being mainly in bodycare, food, consumer products and confectionery.
Copapharm Europe Chairman, Bruno Chorzelewski, said that the company had now become a ‘tangible trading organisation’, and would not only seek to continue the development of the European pharmaceutical and healthcare market for printed packaging, but would also be developing strategic alliances with companies outside Europe supplying common customers and developing new potential customers. He also said that healthy growth had continued despite fierce competition and significant changes in the alliance’s customer base and market. Improvements in supply chain management had also contributed to growth and efficiency.
In June 2008, a management buyout took place at Copapharm Europe shareholder Storey Evans, returning the company to independent status after being part of the MSO Group. Storey Evans remains within Copapharm Europe SCRL. Leading Spanish pharmaceutical printer Artes Graficas Nekar also joined the alliance in 2008 as a partner to Icesa.
Another Copapharm Europe shareholder, Faller, opened a new PharmaLogistikCenter in Berlin this month, a purpose-built logistics centre for the packing, production and order picking of pharmaceutical secondary packaging. Faller took the decision to open the centre as five of the largest German pharmaceutical companies are based in Berlin, several being Faller customers.
Copapharm Europe companies specialise in producing cartons, labels, leaflets and associated services for leading pharmaceutical and healthcare customers, including a number of multi-national pharmaceutical companies. Last year the company, which employs 2310 people, produced 6.1 billion cartons, 3.9 billion leaflets and 1.8 billion labels.
Copapharm’s 10 shareholder companies are Faller (Germany), Packetis (France), Palladio and Zannini (Italy), Goldprint (Belgium), Storey Evans (Great Britain) and Cartonplex, Icesa, Nekar and Pans (Spain). They have a total of 21 manufacturing sites across Europe, in Belgium, France, Germany, Italy, Serbia, Spain, the UK and Ireland. These companies work closely, both individually and collectively, with pharmaceutical manufacturers to supply packaging solutions and requirements. Together, they have a total capacity of 7.8 billion folding carton units, 4.8 billion leaflet units and 2.6 billion label units across Europe.
Further information on Copapharm Europe SCRL is available from the Copapharm Europe website at www.copapharm.com, by emailing info@copapharm.com or by telephoning Sylvia Wieloch on 0049 6732 93 63 52.
ENDS
For further media information or photographs please contact Bridget Summers, Footprint, PO Box 4, Thorpe Park, Leeds LS15 8WX. Tel: +44 (0)113 251 5697. Fax: +44 (0)113 251 5351. E-mail: bridget@fim.org.uk